Patient Note — 55992
progress_notes_55992_1_deid.txt
Demographics & Encounter
Patient ID55992 (PHI redacted)
Age / Gender62 / Male
Date of Service2026-02-13
ProviderNone
FacilityPOTOMAC UROLOGY CENTER - Woodbridge
PayerTricare East
Reason1. 3m Testopel 10
Diagnoses
E29.1
Testicular hypofunction
Medications
Testopel(Testosterone)
Mounjaro(Tirzepatide) 7.5 MG/0.5ML Solution Pen-injector as directed Subcutaneous
CeleBREX
Metoprolol Succinate ER
metFORMIN HCl
Progress Note: [PROVIDER_NAME], PA 02/13/2026
Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com)
Generated for Printing/Faxing/eTransmitting on: 04/21/2026 04:42 AM EDT
1/4
4/21/26, 1:42 AM Print Preview
[PATIENT_NAME] DOB: [DOB] (62 yo M) Acc No. [ACCOUNT_ID] DOS: 02/13/2026
Past Medical History
- Arthritis
- Diabetes
- Low Testosterone
Clinical Summary (HPI)
Low Testosterone: 62yM w/ hx of low testosterone presents for Testopel QTY (10). The patient is overall doing well on Testopel QTY (10+2) every 3 months. He denies any drop-off effect. He has recently donated blood. - - - - - - -- The patient's previous workup history is listed below: Testosterone: 340 (February 2026); 360 (November 2025); 304 (May 2025); 469 (Jan 2025); 422 (Oct 2024); 410 (July 2024); 326 (April 2024); 266 (Jan 2024); 267 (Sept 2023); 238 (June 2023); 164 (Mar 2023); 355 (Dec 2022); 228 (11/22); 265 (7/22); 1030 [5/11/22]; 275 [Oct. 2021], 415 [Apr 2021], 236 [Sep 2020] FT-Calc: 66.6 (May 2025) HCT: 46 (February 2026); 51 (November 2025); 47 (May 2025); 52 (Jan 2025); 50 (Oct 2024); 47 (Jan 2024); 47 (Sept 2023); 47 (Mar 2023); 52 [H] (5/11/22); 50 (10/21) Hepatic: WNL (November 2025); WNL (July [ACCOUNT_ID]); WNL (Jan 2024); ALT 62 (Sept 2023); WNL (5/22) PSA: 0.61 (February 2026); 1.97 (November 2025); 0.60 (Jan 2025); 0.54 (July 2024); 0.47 (Jan 2024); 0.45 (Sept 2023); 0.33 (Mar 2023); 0.44 [May 2022]; 0.28 [Oct. 2021], 0.7 [Sep 2020]. Previous Treatments Medication Gel/cream Current Therapy Testopel? Yes # Testopel placed at last visit 10 + 2 Tpellets Date of last Testopel insertion 04/29/2024
Raw Note (de-identified preview)
4/21/26, 1:42 AM Print Preview
[PATIENT_NAME] DOB: [DOB] (62 yo M) Acc No. [ACCOUNT_ID] DOS: 02/13/2026
[PATIENT_NAME]
62 Y old Male, DOB: [DOB]
Account: [ACCOUNT_ID]: [ACCOUNT_ID]
[ADDRESS], FREDERICKSBURG, VA-[ACCOUNT_ID]
Home: [PHONE]
Guarantor: [PATIENT_NAME] Insurance: Tricare East
PGBA
Referring: [PROVIDER_NAME]
Appointment Facility: POTOMAC UROLOGY CENTER - Woodbridge
Structured Data: How did you hear about us? : Other; Patient's temperature : 97.8; : 11/14/2022
02/13/2026 Testopel: [PROVIDER_NAME], PA
Reason for Appointment
1. 3m Testopel 10
History of Present Illness
Low Testosterone:
62yM w/ hx of low testosterone presents for Testopel QTY (10).
The patient is overall doing well on Testopel QTY (10+2) every 3 months. He denies any drop-off effect. He has recently
donated blood.
- - - - - - --
The patient's previous workup history is listed below:
Testosterone: 340 (February 2026); 360 (November 2025); 304 (May 2025); 469 (Jan 2025); 422 (Oct 2024); 410 (July
2024); 326 (April 2024); 266 (Jan 2024); 267 (Sept 2023); 238 (June 2023); 164 (Mar 2023); 355 (Dec 2022); 228 (11/22);
265 (7/22); 1030 [5/11/22]; 275 [Oct. 2021], 415 [Apr 2021], 236 [Sep 2020]
FT-Calc: 66.6 (May 2025)
HCT: 46 (February 2026); 51 (November 2025); 47 (May 2025); 52 (Jan 2025); 50 (Oct 2024); 47 (Jan 2024); 47 (Sept
2023); 47 (Mar 2023); 52 [H] (5/11/22); 50 (10/21)
Hepatic: WNL (November 2025); WNL (July [ACCOUNT_ID]); WNL (Jan 2024); ALT 62 (Sept 2023); WNL (5/22)
PSA: 0.61 (February 2026); 1.97 (November 2025); 0.60 (Jan 2025); 0.54 (July 2024); 0.47 (Jan 2024); 0.45 (Sept 2023);
0.33 (Mar 2023); 0.44 [May 2022]; 0.28 [Oct. 2021], 0.7 [Sep 2020].
Previous Treatments
Medication Gel/cream
Current Therapy
Testopel? Yes
# Testopel placed at last visit 10 + 2 Tpellets
Date of last Testopel insertion 04/29/2024
Current Medications
Taking
Testopel(Testosterone) 75 MG Pellet as directed Implant
Mounjaro(Tirzepatide) 7.5 MG/0.5ML Solution Pen-injector as directed Subcutaneous
CeleBREX 200 MG Capsule 1 capsule with food Orally Once a day
Metoprolol Succinate ER 25 MG Tablet Extended Release 24 Hour Oral
metFORMIN HCl 500 MG Tablet Oral
Progress Note: [PROVIDER_NAME], PA 02/13/2026
Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com)
Generated for Printing/Faxing/eTransmitting on: 04/21/2026 04:42 AM EDT
1/4
4/21/26, 1:42 AM Print Preview
[PATIENT_NAME] DOB: [DOB] (62 yo M) Acc No. [ACCOUNT_ID] DOS: 02/13/2026
Past Medical History
Arthritis.
Diabetes.
Low Testosterone.
Surgical History
appendectomy 1980
L Testicle Cyst Exition
Family History
Father: unknown
Mother: alive, arthritis, GERD, hypertension, osteoporosis, diagnosed with Hypertension
Social History
Smoking: no Are you a:: nonsmoker.
Recreational drug use: no.
Exercise: no.
Caffeine: yes, frequency:5 a day.
Alcohol: no
Sexually active: yes.
Occupation: [EMPLOYER].
Screening
Allergies
Penicillin
Hospitalization/Major Diagnostic Procedure
No Hospitalization History.
Review of Systems
11 system R